{"id":241782,"date":"2026-09-10T15:48:50","date_gmt":"2026-09-10T10:18:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=241782"},"modified":"2026-10-21T15:46:04","modified_gmt":"2026-10-21T10:16:04","slug":"why-piramal-pharma-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/","title":{"rendered":"Piramal Pharma (PPLPHARMA) Share Price Falls 2.44%: What the Move Shows"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma (PPLPHARMA)<\/a> share price fell to Rs 189.7 today, down 2.44% from the previous close. Market cap was Rs 25,888.06 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;\">Piramal Pharma Share Price is trading at Rs 189.70, down 2.44% today, with a market capitalisation of Rs 25,888.06 crore. The latest Piramal Pharma Share Price move took the stock below its previous close of Rs 194.45 after opening at Rs 194.70 and touching an intraday high of Rs 199.50 before slipping to the day\u2019s low of Rs 189.70. Univest data confirms the move itself, though no company-specific trigger has been identified. For readers tracking Piramal Pharma Share Price Today, the movement matters because it combines a clear share price decline with valuation and profitability metrics that are worth reading together. This Piramal Pharma Stock News note focuses on what the price action shows, how the fundamentals compare with the Healthcare and pharmaceuticals peer set, and what investors should monitor next through Univest.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Piramal_Pharma_PPLPHARMA_Share_Price_Today_Price_Action_Analysis\" title=\"Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis\">Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Piramal_Pharma_PPLPHARMA_Fundamental_Analysis\" title=\"Piramal Pharma (PPLPHARMA) Fundamental Analysis\">Piramal Pharma (PPLPHARMA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Piramal_Pharma\" title=\"Why Investors Are Watching Piramal Pharma\">Why Investors Are Watching Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#About_Piramal_Pharma\" title=\"About Piramal Pharma\">About Piramal Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Track_Piramal_Pharma_Share_Price_on_Univest\" title=\"Track Piramal Pharma Share Price on Univest\">Track Piramal Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Why_is_Piramal_Pharma_Share_Price_falling_today\" title=\"Why is Piramal Pharma Share Price falling today?\">Why is Piramal Pharma Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#What_is_Piramal_Pharma_Share_Price_today\" title=\"What is Piramal Pharma Share Price today?\">What is Piramal Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#What_does_Piramal_Pharma_Share_Price_tell_investors\" title=\"What does Piramal Pharma Share Price tell investors?\">What does Piramal Pharma Share Price tell investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#How_does_Piramal_Pharma_Share_Price_compare_with_the_same_industry\" title=\"How does Piramal Pharma Share Price compare with the same industry?\">How does Piramal Pharma Share Price compare with the same industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Is_Piramal_Pharma_Share_Price_expensive_on_book_value\" title=\"Is Piramal Pharma Share Price expensive on book value?\">Is Piramal Pharma Share Price expensive on book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#What_is_the_EPS_linked_to_Piramal_Pharma_Share_Price\" title=\"What is the EPS linked to Piramal Pharma Share Price?\">What is the EPS linked to Piramal Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#What_are_the_ROE_and_ROCE_for_Piramal_Pharma_Share_Price_analysis\" title=\"What are the ROE and ROCE for Piramal Pharma Share Price analysis?\">What are the ROE and ROCE for Piramal Pharma Share Price analysis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#Does_Piramal_Pharma_Share_Price_have_dividend_support\" title=\"Does Piramal Pharma Share Price have dividend support?\">Does Piramal Pharma Share Price have dividend support?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-piramal-pharma-share-price-fall-today-2026\/#How_can_investors_track_Piramal_Pharma_Share_Price_on_Univest\" title=\"How can investors track Piramal Pharma Share Price on Univest?\">How can investors track Piramal Pharma Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_PPLPHARMA_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 189.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 194.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 4.75 (-2.44%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 194.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 199.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 189.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,888.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma Share Price Today reflects a single-session decline of Rs 4.75, or 2.44%, from the previous close of Rs 194.45 to Rs 189.70. The stock opened near the prior settlement at Rs 194.70, moved up to Rs 199.50, and then touched Rs 189.70, which is also the day low. That range shows Piramal Pharma Share Price was active across the morning band before settling near the lower end of the move. With a market capitalisation of Rs 25,888.06 crore, Piramal Pharma fits the Large Cap category in this article\u2019s context. The Piramal Pharma Share Price fall is therefore best read as a price action event first, followed by a closer look at whether the valuation and return ratios add support or caution.<\/p>\n<p>The Piramal Pharma Share Price Update does not stand alone. A fall of 2.44% in a Large Cap company draws attention because the market is still re-pricing the stock around current earnings and book-value inputs. That makes the next section on Piramal Pharma Fundamental Analysis important for context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Piramal_Pharma_PPLPHARMA_Fundamental_Analysis\"><\/span><strong>Piramal Pharma (PPLPHARMA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,888.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 60.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma (PPLPHARMA) fundamental metrics show P\/B 3.23x, ROE -4.04%, ROCE 1.24%. Read together, these ratios describe the company&#8217;s position rather than a recommendation.<\/p>\n<p>Piramal Pharma has a market capitalisation of Rs 25,888.06 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/B at 3.23x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">45.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.1x to 616.89x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.11x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-4.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.33%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.14%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.25%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.05%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,888.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 771.43 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,467.03 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Piramal Pharma (PPLPHARMA) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Piramal Pharma (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.33%, a difference of -135.66%. Piramal Pharma (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.25%, a difference of -90.64%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,18,683.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,41,310.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,73,078.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">79.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,433.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">101.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,022.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Its ROE of -4.04% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma (PPLPHARMA) has a market capitalisation of Rs 25,888.06 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Piramal_Pharma\"><\/span><strong>Why Investors Are Watching Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Piramal Pharma Share Price fell 2.44% to Rs 189.70, which puts today\u2019s price action directly in focus for Univest readers.<\/li>\n<li>The stock\u2019s P\/B of 3.23 sits above the same-industry median of 2.76, so Piramal Pharma Share Price remains interesting on valuation context.<\/li>\n<li>ROE of -4.04% and ROCE of 1.24% keep profitability in view when reviewing Piramal Pharma Fundamental Analysis.<\/li>\n<li>EPS of -2.36, book value of Rs 60.13 and dividend yield of 0% provide a direct snapshot for Piramal Pharma Share Price Today.<\/li>\n<li>The Healthcare and Pharmaceuticals &amp; Drugs sector comparison shows Piramal Pharma Share Price against a wide peer base of 199 companies.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Piramal_Pharma\"><\/span><strong>About Piramal Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Piramal Pharma operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company is part of the Indian listed pharma universe tracked by Univest, where Piramal Pharma Share Price is assessed alongside peers on market capitalisation, valuation ratios and return metrics. In this note, the business is viewed through the financial lens available here: market value, P\/B, EPS, book value, ROE and ROCE. That makes Piramal Pharma Stock News relevant for readers who want a factual read on price movement and a grounded view of the company\u2019s listed financial profile.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Piramal_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Piramal Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pplpharma\/piramal-pharma-ltd-share-price-today\">Piramal Pharma (PPLPHARMA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>You can track Piramal Pharma Share Price on Univest for live price movement, fundamental ratios, 52-week levels and market insights in one place. The same page helps readers follow Piramal Pharma Share Price Today, Piramal Pharma Stock News and broader company context without switching between sources. Univest also keeps the stock view tied to valuation, sector comparison and updated market data.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Piramal_Pharma_Share_Price_falling_today\"><\/span><strong>Why is Piramal Pharma Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price is down 2.44% to Rs 189.70, with no company-specific catalyst established in the verified data. The move is confirmed by the day\u2019s open, high, low and previous close.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Piramal_Pharma_Share_Price_today\"><\/span><strong>What is Piramal Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price today is Rs 189.70, compared with the previous close of Rs 194.45. The stock moved between Rs 189.70 and Rs 199.50 during the day, keeping price action in focus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Piramal_Pharma_Share_Price_tell_investors\"><\/span><strong>What does Piramal Pharma Share Price tell investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price shows a Large Cap company trading at Rs 25,888.06 crore in market value, with P\/B at 3.23, EPS at -2.36, ROE at -4.04% and ROCE at 1.24%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Piramal_Pharma_Share_Price_compare_with_the_same_industry\"><\/span><strong>How does Piramal Pharma Share Price compare with the same industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price has a P\/B above the same-industry median of 2.76, but its ROE and ROCE are below the industry median and average. That comparison places the stock in a weaker return profile.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Piramal_Pharma_Share_Price_expensive_on_book_value\"><\/span><strong>Is Piramal Pharma Share Price expensive on book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price has a P\/B of 3.23, which is above the same-industry median of 2.76 but below the average of 4.11. The book value per share is Rs 60.13, giving context to the current price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_EPS_linked_to_Piramal_Pharma_Share_Price\"><\/span><strong>What is the EPS linked to Piramal Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The EPS linked to Piramal Pharma Share Price is -2.36 in the latest figures used here. That negative EPS is one reason the stock\u2019s profitability read deserves attention alongside valuation and sector context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_for_Piramal_Pharma_Share_Price_analysis\"><\/span><strong>What are the ROE and ROCE for Piramal Pharma Share Price analysis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price analysis shows ROE at -4.04% and ROCE at 1.24%. Both are below the same-industry medians, so the return profile remains an important part of the stock\u2019s current assessment.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Piramal_Pharma_Share_Price_have_dividend_support\"><\/span><strong>Does Piramal Pharma Share Price have dividend support?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Piramal Pharma Share Price has a dividend yield of 0% in the latest Univest figures. That means the current analysis should focus on price action, valuation and profitability rather than any yield contribution.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_investors_track_Piramal_Pharma_Share_Price_on_Univest\"><\/span><strong>How can investors track Piramal Pharma Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors can track Piramal Pharma Share Price on Univest for live movement, fundamental ratios, market capitalisation, 52-week levels and sector context. It gives a single view of price action and company fundamentals.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Piramal Pharma Share Price falling today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price is down 2.44% to Rs 189.70, with no company-specific catalyst established in the verified data. The move is confirmed by the day\u2019s open, high, low and previous close.\"}},{\"@type\":\"Question\",\"name\":\"What is Piramal Pharma Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price today is Rs 189.70, compared with the previous close of Rs 194.45. The stock moved between Rs 189.70 and Rs 199.50 during the day, keeping price action in focus.\"}},{\"@type\":\"Question\",\"name\":\"What does Piramal Pharma Share Price tell investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price shows a Large Cap company trading at Rs 25,888.06 crore in market value, with P\/B at 3.23, EPS at -2.36, ROE at -4.04% and ROCE at 1.24%.\"}},{\"@type\":\"Question\",\"name\":\"How does Piramal Pharma Share Price compare with the same industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price has a P\/B above the same-industry median of 2.76, but its ROE and ROCE are below the industry median and average. That comparison places the stock in a weaker return profile.\"}},{\"@type\":\"Question\",\"name\":\"Is Piramal Pharma Share Price expensive on book value?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price has a P\/B of 3.23, which is above the same-industry median of 2.76 but below the average of 4.11. The book value per share is Rs 60.13, giving context to the current price.\"}},{\"@type\":\"Question\",\"name\":\"What is the EPS linked to Piramal Pharma Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The EPS linked to Piramal Pharma Share Price is -2.36 in the latest figures used here. That negative EPS is one reason the stock\u2019s profitability read deserves attention alongside valuation and sector context.\"}},{\"@type\":\"Question\",\"name\":\"What are the ROE and ROCE for Piramal Pharma Share Price analysis?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price analysis shows ROE at -4.04% and ROCE at 1.24%. Both are below the same-industry medians, so the return profile remains an important part of the stock\u2019s current assessment.\"}},{\"@type\":\"Question\",\"name\":\"Does Piramal Pharma Share Price have dividend support?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Piramal Pharma Share Price has a dividend yield of 0% in the latest Univest figures. That means the current analysis should focus on price action, valuation and profitability rather than any yield contribution.\"}},{\"@type\":\"Question\",\"name\":\"How can investors track Piramal Pharma Share Price on Univest?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can track Piramal Pharma Share Price on Univest for live movement, fundamental ratios, market capitalisation, 52-week levels and sector context. It gives a single view of price action and company fundamentals.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Piramal Pharma Share Price fell 2.44% to Rs 189.70 today. Market cap stands at Rs 25,888.06 crore.<\/p>\n","protected":false},"author":35,"featured_media":320984,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-241782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["320984"],"rank_math_title":["Piramal Pharma Share Price Today Down 2.44%: What It Shows"],"rank_math_description":["Piramal Pharma Share Price fell 2.44% to Rs 189.70. Review price action, valuation, ROE, ROCE, EPS, book value and peer comparison."],"rank_math_focus_keyword":["Piramal Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Piramal_Pharma_PPLPHARMA_Share_Price_Falls_244_What_the_Move_Shows_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/241782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=241782"}],"version-history":[{"count":5,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/241782\/revisions"}],"predecessor-version":[{"id":320985,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/241782\/revisions\/320985"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/320984"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=241782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=241782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=241782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}